Literature DB >> 17229737

Probing the roles of active site residues in the 3'-5' exonuclease of the Werner syndrome protein.

Jung Min Choi1, Sung Yun Kang, Won Jin Bae, Kyeong Sik Jin, Moonhor Ree, Yunje Cho.   

Abstract

Werner syndrome is a premature aging disease caused by mutations in the WS gene and a deficiency in the function of Werner protein (WRN). The lack of WRN results in a cellular phenotype of genomic instability. WRN belongs to the RecQ DNA helicase family, but unlike other RecQ family members it possesses a functional exonuclease domain. We determined the crystal structure of mWRNexo (residues 31-238) bound to Zn(2+) and the sulfate ion. Compared with the structure of human WRNexo (hWRNexo), notable conformational changes were observed in several active site residues in an H5-H6 loop and in helices H6 and H7 of mWRNexo, presumably because of the presence of sulfate, which mimics the phosphate of substrate DNA. In particular, the side chains of Lys(185) and Tyr(206) were reoriented toward the Zn(2+) ion, whereas the side chain of Arg(190) pointed away from the active site center. Mutational analysis of these conserved residues abolished WRN exonuclease activity, suggesting that these residues play a critical role in the WRNexo activity. Based on substrate modeling and mutational analyses, we propose a mechanism by which WRNexo becomes activated upon substrate DNA binding. We also describe the low resolution trimeric structure of mouse WRNexoL (mWRNexoL, residues 31-330), as elucidated by small angle x-ray scattering (SAXS) analyses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229737     DOI: 10.1074/jbc.M609657200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Engineering oxidoreductases: maquette proteins designed from scratch.

Authors:  Bruce R Lichtenstein; Tammer A Farid; Goutham Kodali; Lee A Solomon; J L Ross Anderson; Molly M Sheehan; Nathan M Ennist; Bryan A Fry; Sarah E Chobot; Chris Bialas; Joshua A Mancini; Craig T Armstrong; Zhenyu Zhao; Tatiana V Esipova; David Snell; Sergei A Vinogradov; Bohdana M Discher; Christopher C Moser; P Leslie Dutton
Journal:  Biochem Soc Trans       Date:  2012-06-01       Impact factor: 5.407

Review 2.  RecQ Helicase Somatic Alterations in Cancer.

Authors:  Megha K Thakkar; Jamie Lee; Stefan Meyer; Vivian Y Chang
Journal:  Front Mol Biosci       Date:  2022-06-15

Review 3.  Structural mechanisms of human RecQ helicases WRN and BLM.

Authors:  Ken Kitano
Journal:  Front Genet       Date:  2014-10-29       Impact factor: 4.599

Review 4.  Werner Syndrome Protein and DNA Replication.

Authors:  Shibani Mukherjee; Debapriya Sinha; Souparno Bhattacharya; Kalayarasan Srinivasan; Salim Abdisalaam; Aroumougame Asaithamby
Journal:  Int J Mol Sci       Date:  2018-11-02       Impact factor: 5.923

5.  The structure of human EXD2 reveals a chimeric 3' to 5' exonuclease domain that discriminates substrates via metal coordination.

Authors:  Jumi Park; Song-Yi Lee; Hanbin Jeong; Myeong-Gyun Kang; Lindsey Van Haute; Michal Minczuk; Jeong Kon Seo; Youngsoo Jun; Kyungjae Myung; Hyun-Woo Rhee; Changwook Lee
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

6.  The Werner syndrome helicase/exonuclease processes mobile D-loops through branch migration and degradation.

Authors:  Patricia L Opresko; Gregory Sowd; Hong Wang
Journal:  PLoS One       Date:  2009-03-13       Impact factor: 3.240

7.  WRN Exonuclease activity is blocked by specific oxidatively induced base lesions positioned in either DNA strand.

Authors:  Zuzanna Bukowy; Jeanine A Harrigan; Dale A Ramsden; Barbara Tudek; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Nucleic Acids Res       Date:  2008-07-25       Impact factor: 16.971

8.  EXD2 promotes homologous recombination by facilitating DNA end resection.

Authors:  Ronan Broderick; Jadwiga Nieminuszczy; Hannah T Baddock; Rajashree Deshpande; Opher Gileadi; Tanya T Paull; Peter J McHugh; Wojciech Niedzwiedz
Journal:  Nat Cell Biol       Date:  2016-01-25       Impact factor: 28.824

9.  Considerations for Sample Preparation Using Size-Exclusion Chromatography for Home and Synchrotron Sources.

Authors:  Robert P Rambo
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.